@article{2021-04-23,
author = {, , , , , },
title = {},
year = {2021},
doi = {10.1007/s11094-021-02364-6},
publisher = {NP «NEICON»},
abstract = {The pharmacokinetic parameters of the parent substance and the injectable dosage form of the new antiplatelet drug 3-methyl-8-(piperazin-1-yl)-7-(thietan-3-yl)-1-ethyl-1H-purine-2,6(3H,7H)-dione hydrochloride in rabbit blood plasma upon intravenous administration were compared and analyzed. The relative bioavailability coefficient was determined to be 0.97.},
URL = {https://repo.bashgmu.ru/publication/2356},
eprint = {https://repo.bashgmu.ru/files/2532},
}